Gut Microbiota Linked to Ovarian Cancer Growth

Researchers discovered that a depletion of specific gut bacteria may influence tumor progression in ovarian cancer.

Updated on Sept. 18, 2026 in Nutrition

A close-up view of a laboratory petri dish and beaker on a sterile workbench, representing scientific research into gut bacteria and cancer.
Researchers identified a significant depletion of Bifidobacterium in the gut microbiota of patients with epithelial ovarian cancer, potentially impacting tumor progression. AI Illustration. Upload story photo >

Scientists have identified a significant depletion of Bifidobacterium in the gut microbiota of patients diagnosed with epithelial ovarian cancer. This gut-based change is linked to altered acetic acid levels that may contribute to tumor development.

Why it matters

Understanding the connection between gut metabolites and cancer progression could open new avenues for treatment. This research highlights how restoring specific bacterial populations may help regulate systemic inflammation and tumor growth.

qPCR analysis and 16S rRNA sequencing revealed a depletion of Bifidobacterium, while gas chromatography-mass spectrometry confirmed lower acetic acid levels. The study observed NRF2/HO-1/GPX4 signaling downregulation in tumor tissues.

The players

Bifidobacterium animalis subsp. lactis

This specific strain of probiotic bacteria was used in the study to demonstrate its potential role in inhibiting tumor growth.

The details

The study found that oral administration of Bifidobacterium animalis subsp. lactis NCU-01 or sodium acetate inhibits tumor growth in mouse models. These treatments were shown to restore intestinal barrier function and promote ferroptosis-related cellular changes in tumor cells.

Timeline

  1. September 18, 2026: The research findings were published online.

Deeper Dive

This research follows a pattern set by investigations into the NRF2/HO-1/GPX4 signaling cascade in oncology. It identifies this specific pathway as a critical regulator of ferroptosis that is suppressed within epithelial ovarian cancer tissues.

While these findings are limited to laboratory and animal models, they suggest that gut health could eventually play a larger role in cancer management. Patients should consult their oncologists regarding established care standards rather than making dietary changes based on preclinical data.

The takeaway

This discovery underscores the critical role of gut-derived metabolites in systemic health and potential tumor suppression. Future research will be necessary to determine how these findings can be safely and effectively translated into human clinical applications.

Further reading

For more on the relationship between diet and health, explore our Nutrition section.

More information

Read the complete peer-reviewed research article published in Nature.

Source note: This article includes information reported by Nature.